Media >> Anadach Webinar
We hope you and yours are keeping safe and well. As we all know, the world is facing an unprecedented challenge as countries combat the spread of the novel Coronavirus (COVID-19) and its impact on their population and economy. The initial confirmed case in Africa was reported in Cairo, Egypt on February 20th 2020. Since then, almost 20,000 cases resulting in over 1000 deaths are reported from 52 countries and territories in Africa. The impact of the health crisis could be grave given the relative weak health systems in several countries. In addition, the global/local economic shut down has triggered/will trigger an economic crisis in several countries which could also affect the health sector. Most African countries have started to take action including increasing awareness of the disease and relevant hygienic practices, encouraging as much teleworking as possible, limiting community spread by effecting varying levels of lockdowns (both local and international) and closing schools, government offices, non essential businesses etc.
Given that about 60% of health care financing in Africa comes from private sources and almost 50% of total health expenditure goes to private health care, the African private sector can work with governments to ensure that “all” the country’s resources are effectively harnessed in an effective response to the pandemic. Previous pandemics and outbreaks such as Ebola have shown us the need for a timely, integrated response that coordinates efforts across all stakeholders and especially the private health sector.
We are fortunate to be hosting a high level panel of stakeholders across the African private sectors including Dr. Amit Thakker (African Business Federation). Dr. Babatunde Omilola (African Development Bank), Ms. Claire Omatseye (West African Health Federation), Mr. Charles Dalton (International Finance Corporation), Ms Zola Msitya (Board of Healthcare Funders, South Africa) and Ms Zouera Yousoufou (Aliko Dangote Foundation to participate in an upcoming webinar ‘’COVID-19 in Africa: Leveraging the Private Healthcare Sector’’ After the presentation, there will be a moderated discussion, operating under the Chatham House Rule and giving as many as possible in attendance an opportunity to ask questions.
We hope that you, your families, colleagues and friends are staying safe during these challenging times, and we hope you will be able to join us virtually on Wednesday 29th April between 12.00 pm and 1.30 pm (GMT)
Please join us by clicking below. If you do have any questions that you would like any of the specific speakers to address, please include them with your registration. If you have any questions about the event, please reach out to Ms Bukayo Hanidu - Bhanidu@anadach.com
Introduction and welcome – Anadach Group
How do you think the African Private Health Care Sector can be effectively
leveraged in the COVID19 epidemic? How can the private sector be best supported to respond
to the pandemic – Dr. Amit Thakker, African Business Federation (download PPT) and Dr. Katlego Mothudi
, Board of Healthcare Funders of Southern Africa (download PPT)
What are the lessons for the role of the private sector from the Ebola Epidemic in
How is the West African Private Health Sector responding to COVID-19? What
are the major challenges? – Mrs. Clare Omatseye, West African Health Federation (download PPT)
How is AfDB supporting the health sector during this pandemic – focus on private
How is IFC supporting the African Private Health and Pharmaceutical sector
during the pandemic? Do you expect your investment priorities to change? - Mr. Charles Dalton
,International Finance Corporation, (download PPT)
As one of the largest philanthropic foundations in Africa, how is ADF supporting
the COVID 19 responses? Ms. Zouera Youssoufou, Aliko Dangote Foundation (download PPT)
Closing – Anadach Group
Q: Just recently we heard in the news that Senegal has developed a test kit for COVID. I am wondering why the level of testing in Senegal is not higher especially since a lot of people are asking that perhaps Nigeria should purchase these kits.
A: Please see below for more information on the test kit developed in Senegal. In terms of testing, Senegal is a smaller country and has done fewer tests than Nigeria – however at the time of the comparison – Senegal (446/million) had done over 8 times as many tests per million population when compared to Nigeria (53/million). But please note this does not take into account any differences in the incidence, spread, population distribution or type of test.
Q: What is the treatment protocol for symptomatic COVID-19 patients in Nigeria?
A：Please refer to the NCDC guidelines at
Q: What steps are Health & Finance Ministers taking to increase National Budgets for Health and Agricultural and Food Production?
A: Unfortunately, we had no public sector speaker(s) during the session, so we are not able to respond accordingly. We suggest you check out other source information including the ECA meeting with Ministers of Finance -
Q: Can we get a breakdown of each country's affliction rate and success rate?
A: Please be informed that this information is provided by Africa CDC (@AfricaCDC) on twitter daily.
Q: Funding options. How have they changed post-COVID? Can you predict what changes healthcare delivery will look like in LMIC after this pandemic?
In the short term the challenge for many services providers will be liquidity and working capital. The entity’s underlying financial profile—for example, did they already have cash flow issues before COVID—and country nuances such as the length and nature of the lockdown, will impact their financial performance and funding requirement. We envisage a
period of +/- 12 months where working capital support will be required. Thereafter (hopefully) markets should return to normal. It is likely that during this period of uncertainty some larger capital projects may be put on hold and taken up again towards the end of 2020.
Governments place more emphasis on health system strengthening and coordination. This includes more robust approaches to working with the private sector.
Continuing willingness to embrace new models of delivery (for example, telemedicine) while examining how this can now be fully embedded into service delivery models.
Private models moving towards systems and not silos. For example, hospitals integrating with clinics and diagnostics providers to help coordinate care better.
Greater emphasis on social and private insurance. A steady reduction in out-of- pocket dependency.
A gradual move away from fee-for-service payment models in favor of financing models more based on improved value for money, including payment based on outcomes measurement.
Q: How should government provide an enabling environment for the private sector participation?
A：By establishing formal mechanisms for private sector engagement. As the custodian of a country’s health services, governments can help identify the role expected to be played by the private health sector. This could be direct support to the public sector or a strengthening of pure private-focused model serving an insured population. Engagement with private health federations should be highly advantageous assuming the risk of vested interests are removed.
Q：What are the investment opportunities for impact investors in health sectors?
A： To support companies as they respond to the five areas of change in how health care is delivered highlighted in question number 1. Also, to support sustainable business models that can help with prevention or early diagnosis and treatment of noncommunicable diseases. Finally, to advance the uptake of relevant technology to bring down costs, improve quality, or expand access to services.
Q: The private sector’s role in Africa’s fragile states?
A: The private sector in all forms—not-for-profit, for-profit, small and medium-sized enterprises—has a role to play in fragile states. In most fragile states in Africa, the private sector is still in its infancy. Linking to response 2 above, it is important to support governments in establishing clear strategies for their health system and confirming the role to be played by the private sector.
The private sector’s role encompasses appropriately designed services that align with ability-to-pay considerations. Those entities with the right business models have the potential to expand access to critical services addressing both communicable and non-communicable disease challenges.
For IFC, in addition to making investments, we expect to make a difference by promoting high quality care and ethical practices. We have developed an advisory service—the IQ-Health Care Tool— for those institutions wishing to integrate process and quality improvement into their businesses, particularly in low-resource countries where government is stretched or doesn’t have the capacity to set or monitor standards. Furthermore, we recently launched the Ethical Principles in Health Care (EPiHC) initiative that we encourage the private sector to support and join.